Hepatitis C Virus Interactive Patient Flow Model
Forecast the market for Hepatitis C virus across 45 countries through 2030.
The patient flow model enables you to understand:
- How different treatment patterns will affect the size of the HCV patient population
- How commercial objectives for your HCV brands need to change in response to reimbursement and policy shifts among payers
- Where you should focus your commercial strategy to maximize revenue from a shrinking population
- How restricting HCV treatment based on disease severity will affect your asset’s commercial viability
Assess the global Hepatitis C virus landscape.
Forecasts through 2030 for HCV patient population with data by country, region and treatment scenario. Contact us to learn more.